New York State Common Retirement Fund Biotechnology

New York State Common Retirement Fund

$68.1 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ATNM Actinium Pharmaceuticals, Inc.	$37M	$11,000 0.0% of portfolio	6,737	Q2 2024 Reduced 46.46%
ABOS Acumen Pharmaceuticals, Inc.	$59.9M	$11,000 0.0% of portfolio	9,800	Q3 2024 Reduced 76.89%
AVTE Aerovate Therapeutics, Inc.	$65.5M	$11,000 0.0% of portfolio	4,294	Q2 2024 Reduced 0.42%
ATOS Atossa Therapeutics, Inc.	$106M	$11,000 0.0% of portfolio	15,800	Q3 2024 Reduced 82.0%
CRDF Cardiff Oncology, Inc.	$172M	$11,000 0.0% of portfolio	3,600	Q3 2024 Reduced 91.63%
PBYI Puma Biotechnology, Inc.	$160M	$11,000 0.0% of portfolio	3,600	Q3 2024 Reduced 88.39%
APLT Applied Therapeutics Inc.	$17.8M	$10,000 0.0% of portfolio	21,200	Q3 2024 Reduced 45.5%
CADL Candel Therapeutics, Inc.	$152M	$10,000 0.0% of portfolio	1,700	Q3 2024 Reduced 90.0%
PEPG Pep Gen Inc.	$28.8M	$9,000 0.0% of portfolio	6,485	Q2 2024 Added 0.08%
STRO Sutro Biopharma, Inc.	$40.2M	$9,000 0.0% of portfolio	13,625	Q2 2024 Added 1.54%
TNGX Tango Therapeutics, Inc.	$604M	$9,000 0.0% of portfolio	6,576	Q3 2024 Reduced 57.23%
TCRX T Scan Therapeutics, Inc.	$32.4M	$9,000 0.0% of portfolio	6,169	Q3 2024 Reduced 69.3%
ALXO Alx Oncology Holdings Inc	$20M	$8,000 0.0% of portfolio	12,522	Q2 2024 Reduced 0.98%
DSGN Design Therapeutics, Inc.	$224M	$8,000 0.0% of portfolio	2,026	Q4 2023 Reduced 3.06%
BDTX Black Diamond Therapeutics, Inc.	$90.8M	$7,000 0.0% of portfolio	4,400	Q3 2024 Reduced 79.34%
IPSC Century Therapeutics, Inc.	$34.2M	$7,000 0.0% of portfolio	13,743	Q1 2024 Reduced 0.21%
FHTX Foghorn Therapeutics Inc.	$254M	$7,000 0.0% of portfolio	1,871	Q2 2024 Reduced 22.75%
IGMS Igm Biosciences, Inc.	$36.8M	$7,000 0.0% of portfolio	6,512	Q2 2024 Added 0.28%
MGNX Macrogenics Inc	$94.6M	$7,000 0.0% of portfolio	5,244	Q3 2024 Reduced 77.63%
NAUT Nautilus Biotechnology, Inc.	$91M	$7,000 0.0% of portfolio	8,626	Q2 2024 Reduced 0.01%
OVID Ovid Therapeutics Inc.	$29.6M	$6,000 0.0% of portfolio	18,986	Q2 2024 Added 1.67%
EDIT Editas Medicine, Inc.	$188M	$5,000 0.0% of portfolio	4,394	Q3 2024 Reduced 84.74%
KOD Kodiak Sciences Inc.	$270M	$5,000 0.0% of portfolio	1,631	Q2 2024 Added 2.51%
STTK Shattuck Labs, Inc.	$31.4M	$5,000 0.0% of portfolio	5,600	Q3 2024 Reduced 79.03%
HOWL Werewolf Therapeutics, Inc.	$31M	$5,000 0.0% of portfolio	5,100	Q3 2024 Reduced 87.22%
XBIT X Biotech Inc.	$91.3M	$5,000 0.0% of portfolio	1,600	Q3 2024 Reduced 92.63%
INMB Inmune Bio, Inc.	$41.5M	$4,000 0.0% of portfolio	500	Q3 2024 Reduced 95.69%
TNYA Tenaya Therapeutics, Inc.	$36M	$4,000 0.0% of portfolio	7,039	Q2 2024 Added 0.49%
VRCA Verrica Pharmaceuticals Inc.	$327M	$4,000 0.0% of portfolio	9,076	Q2 2024 Reduced 7.09%
PRLD Prelude Therapeutics Inc	$29.8M	$3,000 0.0% of portfolio	3,622	Q3 2024 Reduced 81.06%
ADGI Adagio Therapeutics, Inc.	$505M	$2,000 0.0% of portfolio	4,000	Q3 2024 Reduced 95.2%
OCGN Ocugen, Inc.	$217M	$2,000 0.0% of portfolio	2,600	Q3 2024 Reduced 97.49%
CABA Cabaletta Bio, Inc.	$43.8M	$1,000 0.0% of portfolio	990	Q3 2024 Reduced 98.8%
ELEV Elevation Oncology, Inc.	$8.85M	$1,000 0.0% of portfolio	5,200	Q3 2024 Reduced 86.97%
GBIO Generation Bio Co.	$30.7M	$1,000 0.0% of portfolio	2,682	Q2 2024 Added 0.86%
LCTX Lineage Cell Therapeutics, Inc.	$168M	$1,000 0.0% of portfolio	3,319	Q2 2024 Added 0.82%
PYXS Pyxis Oncology, Inc.	$40M	$1,000 0.0% of portfolio	600	Q3 2024 Reduced 98.08%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.